BCRX
BioCryst Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.20B
P/E Ratio
—
EPS
$-1.77
Beta
0.56
52W High
$10.46
52W Low
$6.00
50-Day MA
$8.96
200-Day MA
$7.92
Dividend Yield
—
Profit Margin
-51.70%
Forward P/E
74.07
PEG Ratio
9.39
About BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $885.72M |
| Gross Profit (TTM) | $678.70M |
| EBITDA | $326.46M |
| Operating Margin | -2.45% |
| Return on Equity | -1925.00% |
| Return on Assets | 42.60% |
| Revenue/Share (TTM) | $4.06 |
| Book Value | $-2.18 |
| Price-to-Book | 56.59 |
| Price-to-Sales (TTM) | 2.48 |
| EV/Revenue | 3.093 |
| EV/EBITDA | 7.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 7.50% |
| Shares Outstanding | $254.16M |
| Float | $220.83M |
| % Insiders | 1.15% |
| % Institutions | 101.08% |
Historical Volatility
HV 10-Day
38.94%
HV 20-Day
48.06%
HV 30-Day
49.30%
HV 60-Day
47.40%
HV Rank
77.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($21.30 target)
3
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026